ÂÜÀòÂÒÂ×

Rinat Tabakman is currently the VP of Development at KAHR-Medical Ltd., a biotechnology company focused on novel immunotherapeutic drug platforms for cancer treatment. Prior to this role, Rinat held various positions, including Senior Scientist in Pharmacology & Toxicology at XTLBio, Postdoctoral Fellow at the Hebrew University of Jerusalem, and Head of the Pediatric Neuromuscular Research Laboratory at Hadassah Medical Center. Rinat's extensive experience also includes serving as Director of Preclinical Development at BiolineRx. Rinat earned a PhD in Pharmacology from The Hebrew University of Jerusalem.